Literature DB >> 20674046

Proteins interacting with nicotinic acetylcholine receptors: expanding functional and therapeutic horizons.

Andrew K Jones1, Steven D Buckingham, David B Sattelle.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that carry out the fast actions of the neurotransmitter acetylcholine (ACh). Over the past 30 years, it has become clear that the activity of nAChRs is dependent on their interaction with a host of proteins, and the number of these that have been identified has increased considerably with recent large-scale proteomic analyses. This review focuses on these interacting proteins, discussing how they regulate a wide range of functions including receptor assembly, and trafficking to and from the cell surface, as well as how they directly modulate functional characteristics such as sensitivity and the degree of response to ACh. Mutations giving rise to disease states highlight the importance of these interacting proteins. Here, we consider their potential as future therapeutic targets for treating diseases associated with altered nAChR function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674046     DOI: 10.1016/j.tips.2010.07.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  16 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Looking below the surface of nicotinic acetylcholine receptors.

Authors:  Clare Stokes; Millet Treinin; Roger L Papke
Journal:  Trends Pharmacol Sci       Date:  2015-06-08       Impact factor: 14.819

Review 3.  Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.

Authors:  Sharon R Letchworth; Paul Whiteaker
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

4.  The role of intracellular linkers in gating and desensitization of human pentameric ligand-gated ion channels.

Authors:  David Papke; Claudio Grosman
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

Review 5.  Prefrontal neuromodulation by nicotinic receptors for cognitive processes.

Authors:  Renata dos Santos Coura; Sylvie Granon
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

6.  Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.

Authors:  F Guzmán-Mejía; C López-Rubalcava; C González-Espinosa
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-18       Impact factor: 4.147

7.  mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.

Authors:  Yan-Gang Sun; Vanessa Rupprecht; Li Zhou; Rajan Dasgupta; Frederik Seibt; Michael Beierlein
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

8.  Cholinergic excitation in mouse primary vs. associative cortex: region-specific magnitude and receptor balance.

Authors:  Michael K Tian; Craig D C Bailey; Evelyn K Lambe
Journal:  Eur J Neurosci       Date:  2014-05-15       Impact factor: 3.386

Review 9.  Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery.

Authors:  Gwen McCaffrey; Thomas P Davis
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

10.  Tyrosine phosphorylation differentially fine-tunes ionotropic and metabotropic responses of human α7 nicotinic acetylcholine receptor.

Authors:  Juan Facundo Chrestia; Ariana Bruzzone; María Del Carmen Esandi; Cecilia Bouzat
Journal:  Cell Mol Life Sci       Date:  2021-05-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.